IDEXX Laboratories, Inc. (IDXX:NASDAQ) closed at $704.23 on November 13, 2026, up 0.89% on the day. The stock trades 8.5% below its 52-week high of $769.98 and 40.7% above its 52-week low of $500.61. Over the past year, it gained 2.1%. IDEXX Laboratories, Inc. is part of the Health Care sector (Biotechnology: In Vitro & In Vivo Diagnostic Substances).
In 252 trading sessions since November 13, 2025, IDXX closed higher on 132 days (52%). Its best day was November 2, 2026 (+21.85%) and its worst was May 11, 2026 (-5.02%). The stock moved 10% or more in a single session 1 time. It opened at least 5% above the previous day's high 1 time.
IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. The company provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. It also offers diagnostic and health-monitoring products for livestock, poultry, and dairy markets; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and oth...
Find more stocks like IDXX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.